CERO THERAPEUTICS HOLDINGS, INC. Notes Payable, Current
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Notes Payable, Current of $1.40 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2023-11-09
- 2023-09-30: Notes Payable, Current $1.40M.
- 2023-06-30: Notes Payable, Current $1.18M.
- 2022-12-31: Notes Payable, Current $650.00K.
| Period end | Notes Payable, Current |
|---|---|
| 2023-09-30 | $1.40M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.18M 10-Q · filed 2023-08-14 |
| 2022-12-31 | $650.00K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |